Stockscreener 앱 받기
61.70
1.93%
1.17
시간 외 거래:
62.00
0.30
+0.49%
전일 마감가:
$60.53
열려 있는:
$60
하루 거래량:
1.52M
Relative Volume:
0.85
시가총액:
$2.07B
수익:
$401.09M
순이익/손실:
$32.64M
주가수익비율:
-56.09
EPS:
-1.1
순현금흐름:
$-120.51M
1주 성능:
-3.98%
1개월 성능:
-20.08%
6개월 성능:
-57.15%
1년 성능:
-20.11%
1일 변동 폭
$59.72
$62.50
1주일 범위
$59.72
$66.44
52주 변동 폭
$59.72
$177.37
Transmedics Group Inc Stock (TMDX) Company Profile
명칭
Transmedics Group Inc
전화
(978) 552-0900
주소
200 MINUTEMAN ROAD, ANDOVER, MA
TMDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
61.70 | 2.07B | 401.09M | 32.64M | -120.51M | 0.94 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-11-22 | 다운그레이드 | Needham | Buy → Hold |
| 2024-10-29 | 재확인 | Needham | Buy |
| 2024-10-29 | 재확인 | Oppenheimer | Outperform |
| 2024-09-24 | 개시 | Robert W. Baird | Outperform |
| 2024-08-21 | 개시 | Needham | Buy |
| 2024-06-06 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-06-04 | 개시 | Stephens | Overweight |
| 2024-03-28 | 개시 | Piper Sandler | Overweight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2022-08-02 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-10-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2019-05-28 | 개시 | Canaccord Genuity | Buy |
| 2019-05-28 | 개시 | Cowen | Outperform |
| 2019-05-28 | 개시 | JP Morgan | Overweight |
| 2019-05-28 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
Transmedics Group Inc 주식(TMDX)의 최신 뉴스
TransMedics Group (NASDAQ:TMDX) Reaches New 1-Year LowHere's Why - MarketBeat
TransMedics Group (NASDAQ:TMDX) Stock Price Down 4.4%Here's Why - MarketBeat
Geode Capital Management LLC Has $119.94 Million Holdings in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
JP Morgan Downgrades TransMedics Group (TMDX) - MSN
TransMedics Group (NASDAQ:TMDX) Shares Gap DownWhat's Next? - MarketBeat
Learn to Evaluate (TMDX) using the Charts - Stock Traders Daily
TransMedics Group (NASDAQ:TMDX) Receives "Neutral" Rating from JPMorgan Chase & Co. - MarketBeat
TransMedics Stock Plunges 57.5% in Three Months: What's Next? - MSN
TransMedics Group's SWOT analysis: organ transplant tech stock faces growth hurdles - Investing.com Canada
TransMedics Group's SWOT analysis: organ transplant tech stock faces growth hurdles By Investing.com - Investing.com South Africa
TMDX stock touches 52-week low at $64.83 amid market shifts By Investing.com - Investing.com South Africa
TMDX stock touches 52-week low at $64.83 amid market shifts - Investing.com
TransMedics reports inducement grants under Nasdaq listing rule - Medical Buyer
Research Analysts Set Expectations for TMDX Q3 Earnings - MarketBeat
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Kilgore News Herald
TransMedics Welcomes New CFO with $1.4M Equity Package; Grants Strategic Inducement Awards - StockTitan
Q1 EPS Estimate for TransMedics Group Decreased by Analyst - MarketBeat
Transmedics Group Inc (TMDX-Q) QuotePress Release - The Globe and Mail
Wellington Management Group LLP Reduces Stock Holdings in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Is TransMedics Stock A Buy Before 2025? - Barchart
Is TransMedics Stock a Buy Before 2025? - AOL
TMDX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Announces Investigation into TransMedics Group, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm - The Eastern Progress Online
TransMedics Group (NASDAQ:TMDX) shareholders are still up 265% over 5 years despite pulling back 3.4% in the past week - Simply Wall St
TransMedics shares target cut, keeps rating on revenue growth - Investing.com
TransMedics shares target cut, keeps rating on revenue growth By Investing.com - Investing.com UK
Robert W. Baird Issues Pessimistic Forecast for TransMedics Group (NASDAQ:TMDX) Stock Price - MarketBeat
TransMedics Group (NASDAQ:TMDX) Earns Hold Rating from Needham & Company LLC - MarketBeat
TransMedics Group (NASDAQ:TMDX) Price Target Cut to $90.00 by Analysts at Piper Sandler - MarketBeat
Beyond The Numbers: 13 Analysts Discuss TransMedics Gr Stock - Benzinga
TransMedics down 3% during analyst day meeting - Nasdaq
TransMedics Group Rings the Opening Bell - Nasdaq
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Bullseye Asset Management LLC - MarketBeat
Zacks Investment Management Buys New Stake in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics Group, Inc. (TMDX): A Bull Case Theory - Insider Monkey
TransMedics expands fleet for organ transport By Investing.com - Investing.com UK
Is TMDX Stock a Buy, Sell or Hold at a P/S Multiple of 5.02X? - MSN
Pier Capital LLC Sells 12,183 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
Nvidia Corp (NVDA-Q) QuotePress Release - The Globe and Mail
Down Over 60%, Is TransMedics Stock a Buy on the Dip? - Yahoo Finance
Rockefeller Capital Management L.P. Takes $1.60 Million Position in TransMedics Group, Inc. (NASDAQ:TMDX) - MarketBeat
TransMedics to Host Investor & Analyst Day on December 10, 2024 - Kilgore News Herald
TransMedics Reports Third Quarter 2024 Financial Results - The Eastern Progress Online
Where are the Opportunities in (TMDX) - Stock Traders Daily
Why TransMedics Stock Plummeted Today - AOL
Transmedics Group (TMDX) Stock Decline: Reasons Behind the Movement - GuruFocus.com
Why Transmedics Group Stock Plummeted 21% This Week - AOL
TMDX stock touches 52-week low at $68.8 amid market shifts - Investing.com Nigeria
TransMedics Group Inc (TMDX) Shares Gap Down to $68.98 on Dec 5 - GuruFocus.com
3 Cheap Stocks to Buy Now - The Motley Fool
TransMedics chief commercial officer sells $93,657 in stock By Investing.com - Investing.com Nigeria
TransMedics chief commercial officer sells $93,657 in stock - Investing.com
Transmedics Group Inc (TMDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Transmedics Group Inc 주식 (TMDX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Khayal Tamer I | Chief Commercial Officer |
Dec 02 '24 |
Sale |
86.40 |
1,084 |
93,658 |
20,843 |
| Khayal Tamer I | Chief Commercial Officer |
Nov 11 '24 |
Option Exercise |
38.46 |
1,458 |
56,075 |
22,301 |
| Khayal Tamer I | Chief Commercial Officer |
Nov 11 '24 |
Sale |
90.04 |
1,458 |
131,278 |
20,843 |
| Basile Edward M | Director |
Nov 05 '24 |
Option Exercise |
28.12 |
6,750 |
189,810 |
7,482 |
| Basile Edward M | Director |
Nov 05 '24 |
Sale |
83.55 |
6,750 |
563,994 |
732 |
| Khayal Tamer I | Chief Commercial Officer |
Nov 01 '24 |
Option Exercise |
13.28 |
1,083 |
14,382 |
21,926 |
| Khayal Tamer I | Chief Commercial Officer |
Nov 01 '24 |
Sale |
82.64 |
1,083 |
89,499 |
20,843 |
1.54%
자본화:
|
볼륨(24시간):